High prevalence of systemic rheumatic diseases in women with type 1 diabetes

J Diabetes Complications. 2018 Aug;32(8):737-739. doi: 10.1016/j.jdiacomp.2018.06.001. Epub 2018 Jun 7.

¹ Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, United States of America; University of Missouri-Kansas City School of Medicine, Kansas City, MO, United States of America.
² Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, United States of America.
³ Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, United States of America.
⁴ Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, MO, United States of America. Electronic address: jing.hughes@wustl.edu.

Abstract

Background: The prevalence of systemic rheumatic diseases (SRDs) in T1DM has not been described.

Method: This observational study compares SRD prevalence across age, race, and gender in 1,212 adults with T1DM.

Findings: There is an age-dependent enrichment of SRDs in women with T1DM: 9.2% prevalence in women overall and 14% in women over age 50.

Conclusion: Clinicians taking care of older women with T1DM should monitor for these SRDs.

Keywords: Autoimmunity; Epidemiology; Rheumatic diseases; Type 1 diabetes.